A pharmaceutical company, was the market leader for over a decade with the only treatment for a rare disease.
As the client was preparing for competition from a new drug, they wanted to learn from past cases how incumbents defended their market share against disruptive market entry by a novel drug with better safety or dose profile.
10EQS delivered a list of drug analogs and an analysis of each analog; recommending cases for in-depth research. Next, 10EQS delivered a deep-dive analysis of drug launches, market results, key factors that set up competitor dynamics in three selected cases.
10EQS delivered an analysis of success factors that led incumbent to hang on to their market share; recommendations for incumbent defense strategies relevant to the client’s unique rare disease context.
Please reach out to us if you are interested in learning more.